How Pluri Is Mass-Producing Cells to Solve Global Health & Food Challenges скачать в хорошем качестве

How Pluri Is Mass-Producing Cells to Solve Global Health & Food Challenges

https://pluri-biotech.com/ From the New York Stock Exchange, Jane King sits down with Yaky Yanay, CEO & President of Pluri (NASDAQCM, TASE: PLUR), to explore how the company is revolutionizing biotechnology through large-scale cell expansion. Yanay describes Pluri as the “iPhone of biotechnology”—a unified, patented platform capable of producing human, animal, and plant cells at massive scale. With over two decades of research and more than 250 patents, Pluri is applying its technology across regenerative medicine, aesthetics, food tech, agriculture, and cultivated meat. The conversation covers: How Pluri’s 3D cell expansion platform enables scalable, cost-efficient cell manufacturing Why cell-based solutions could be critical for feeding and healing a growing global population Pluri’s upcoming exosome-based aesthetic products launching in 2026 Applications in wound healing, orthopedics, therapeutics, and cultivated coffee, cocoa, meat, and seafood How biotechnology is expanding far beyond traditional pharma As climate pressure, supply constraints, and healthcare demands grow, Pluri aims to provide real, science-backed solutions using one powerful cell-production platform. 🔗 Learn more: https://pluri-biotech.com/ 📈 Ticker: NASDAQ, TASE: PLUR 🐦 X: @Pluribiotech